Can Vistaril (hydroxyzine) cause priapism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine (Vistaril) Can Cause Priapism

Yes, hydroxyzine (Vistaril) can cause priapism, as documented in case reports, though it is a rare adverse effect related to its alpha-adrenergic blocking properties. 1

Mechanism of Action

Hydroxyzine-induced priapism occurs through:

  • Alpha-adrenergic receptor blockade in the corpora cavernosa of the penis
  • Inhibition of the normal sympathetic input necessary for penile detumescence
  • Disruption of the balance between tumescence and detumescence mechanisms

Risk Factors and Considerations

  • Priapism is more commonly associated with:

    • Antipsychotic medications (account for ~50% of drug-related priapism cases) 2
    • Alpha-blockers (like terazosin) 3
    • Certain antidepressants
  • Hydroxyzine-related priapism:

    • Can occur at both therapeutic doses and in overdose situations
    • Has been documented in case reports, including a patient who took hypercompliant doses (200-600 mg) 1
    • May occur without warning and without dose-dependent relationship

Clinical Implications

  • Priapism is a urologic emergency requiring immediate intervention
  • Defined as a persistent, painful erection lasting more than 4 hours without sexual stimulation
  • Ischemic priapism (most common type) is characterized by:
    • Blood gas values showing hypoxia (PO2 ≤30 mmHg)
    • Hypercapnia (PCO2 ≥60 mmHg)
    • Acidosis (pH <7.25) 4

Management of Hydroxyzine-Induced Priapism

If priapism occurs while taking hydroxyzine:

  1. Immediate discontinuation of hydroxyzine
  2. Urgent urological consultation as this is a medical emergency
  3. First-line treatment: Intracavernosal phenylephrine (preferred sympathomimetic agent)
    • Diluted with normal saline to 100-500 μg/mL
    • Administered in 1 mL injections every 3-5 minutes for up to 1 hour 5, 4
  4. Aspiration with or without irrigation if phenylephrine alone is unsuccessful 5
  5. Surgical intervention (distal shunting) if pharmacologic measures fail 5

Monitoring During Treatment

  • Blood pressure and heart rate monitoring is essential during treatment with sympathomimetics 5
  • ECG monitoring is recommended in patients with cardiovascular risk factors 4
  • Patients should be observed for symptoms like hypertension, headache, bradycardia, tachycardia, and cardiac arrhythmias 5

Prevention and Patient Education

  • Patients taking hydroxyzine should be informed about this rare but serious side effect
  • Early recognition and reporting of prolonged erections (>4 hours) is critical
  • Prompt treatment is essential to prevent permanent erectile dysfunction, which becomes increasingly likely after 18-36 hours of ischemia 4

Clinical Pearls

  • Time is critical in managing priapism - treatment efficacy decreases significantly after 48 hours
  • Risk of permanent erectile dysfunction increases dramatically after 18 hours of ischemia
  • Phenylephrine is the preferred agent for treatment due to its selective alpha-1 adrenergic properties and lower risk of cardiovascular side effects compared to other sympathomimetics 5

When prescribing hydroxyzine, clinicians should be aware of this rare but potentially serious adverse effect and educate patients accordingly.

References

Research

Hydroxyzine-induced priapism.

The American journal of emergency medicine, 2021

Guideline

Priapism Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.